Study reveals significant global disparities in cancer care across different countries

Researchers address increasing rates of cancer incidence and mortality in developing countries, and challenges in accessing treatments.

2024-11-18

(Press-News.org) A recent analysis reveals striking disparities in the cost and availability of cancer drugs across different regions of the globe, with significant gaps between high- and low-income countries. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society.

The analysis, which drew on relevant published studies and reviews related to cancer and the availability of cancer treatments, predicts that there will be an estimated 28.4 million new cancer cases worldwide in 2040 alone. In the coming years, cancer incidence is expected to increase most significantly in low-income countries. Cancer mortality rates are also increasing in low-income countries, whereas they have leveled off in developed countries.

Research indicates that inequity in access to therapy, lack of proper screening, persistent carcinogenic risk factors, and inadequate healthcare infrastructure are major contributors to the higher cancer incidence and cancer-related mortality rates observed in low-income countries compared with high-income countries. Also, clinicians’ current understanding of cancer and its optimal treatment is primarily based on research conducted in high-income countries, whose residents may differ from individuals in middle- and low-income countries.

Studies reveal that economics can be a major challenge for optimal cancer care around the world. Newer cancer drugs such as immunotherapy medications can cost thousands of dollars more per year than standard chemotherapy. Also, low-income countries spend less of their total gross domestic product on cancer care than high-income countries, yet they often must pay more for the same essential cancer drugs.

“Cancer incidence and mortality are on the rise globally and are expected to disproportionately affect people in low- and middle-income countries. Unfortunately, access to newer cancer therapeutics is far more restricted in low- and middle-income countries due to prohibitive costs,” said senior author Fadlo R. Khuri, MD, of the American University of Beirut Medical Center, in Lebanon. “In this paper, we analyze the data and propose a few solutions that could help alleviate these worsening disparities—including the use of quality generics and biosimilars and the implementation of universal healthcare coverage and international medical funding.”

Additional information
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. A free abstract of this article will be available via the CANCER Newsroom upon online publication. For more information or to obtain a PDF of any study, please contact: Sara Henning-Stout, newsroom@wiley.com

Full Citation:
“Global Disparities in Cancer Care: Bridging the Gap in Affordability and Access to Medications between High and Low-Income Countries.” Arafat H. Tfayli, Laura N. El-Halabi, and Fadlo R. Khuri. CANCER; Published Online: November 18, 2024 (DOI: 10.1002/cncr.35590).

URL Upon Publication: http://doi.wiley.com/10.1002/cncr.35590

Author Contact: Simon Kachar, Executive Director of Communications at the American University of Beirut, at sk158@aub.edu.lb

About the Journal    
CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online. Follow CANCER on X @JournalCancer and Instagram @ACSJournalCancer, and stay up to date with the American Cancer Society Journals on LinkedIn.

About Wiley     
Wiley is one of the world’s largest publishers and a trusted leader in research and learning. Our industry-leading content, services, platforms, and knowledge networks are tailored to meet the evolving needs of our customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. We empower knowledge-seekers to transform today’s biggest obstacles into tomorrow’s brightest opportunities. For more than two centuries, Wiley has been delivering on its timeless mission to unlock human potential. Visit us at Wiley.com. Follow us on Facebook, X, LinkedIn and Instagram.

END

ELSE PRESS RELEASES FROM THIS DATE:

Proactively screening diabetics for heart disease does not improve long-term mortality rates or reduce future cardiac events, new study finds

2024-11-18

While coronary heart disease and diabetes are often seen in the same patients, a diagnosis of diabetes does not necessarily mean that patients also have coronary heart disease, according to a new study from researchers at Intermountain Health in Salt Lake City. The Intermountain study found that proactively screening patients with diabetes 1 and 2 for coronary heart disease who have not shown symptoms of heart problems does not improve long-term mortality rates, nor does it lower the chance of them ...

New model can help understand coexistence in nature

2024-11-18

Different species of seabirds can coexist on small, isolated islands despite eating the same kind of fish. A researcher at Uppsala University has been involved in developing a mathematical model that can be used to better understand how this ecosystem works. “Our model shows that coexistence occurs naturally when species differ in their ability to catch fish and to efficiently fly long distances to the area where they catch fish,” says Claus Rüffler, Associate Professor of Animal Ecology at Uppsala University. Seabirds can breed in very large colonies, sometimes consisting of several hundred thousand pairs. Ecologists working ...

National Poll: Some parents need support managing children's anger

2024-11-18

ANN ARBOR, Mich. – Many parents are all too familiar with angry outbursts from their children, from sibling squabbles to protests over screen time limits. But some parents may find it challenging to help their kids manage intense emotions. One in seven think their child gets angrier than peers of the same age and four in 10 say their child has experienced negative consequences when angry, a new national poll suggests. Seven in 10 parents even think they sometimes set a bad example of handling anger themselves, according to the University of Michigan Health ...

Political shadows cast by the Antarctic curtain

2024-11-18

The scientific debate around the installation of a massive underwater curtain to protect Antarctic ice sheets from melting lacks its vital political perspective. A Kobe University research team argues that the serious questions around authority, sovereignty and security should be addressed proactively by the scientific community to avoid the protected seventh continent becoming the scene or object of international discord. A January 2024 article in Nature put the spotlight on a bold idea originally proposed by Finnish researchers to save the West Antarctic ...

Scientists lead study on ‘spray on, wash off’ bandages for painful EB condition

2024-11-18

Research into new bandaging aims to ease the agony experienced by those living with genetic skin condition Epidermolysis Bullosa (EB), commonly referred to as 'butterfly skin'. Scientists at Maynooth University in Ireland are leading research into whether ‘spray on, wash off’ bandages will be a viable alternative to those currently used, which can cause severe pain when applied and removed. EB, which affects over 500,000 children and adults worldwide including 5,000 in the UK and 300 ...

A new discovery about pain signalling may contribute to better treatment of chronic pain

2024-11-18

When pain signals are passed along the nervous system, proteins called calcium channels play a key role. Researchers at Linköping University, Sweden, have now pinpointed the exact location of a specific calcium channel fine-tuning the strength of pain signals. This knowledge can be used to develop drugs for chronic pain that are more effective and have fewer side effects. Pain sensations and other information are mainly conducted through our nervous system as electrical signals. Yet at decisive moments, this information is converted to biochemical signals, in the form of specific molecules. To develop future drugs ...

Migrating birds have stowaway passengers: invasive ticks could spread novel diseases around the world

2024-11-18

Ticks travel light, but they carry pathogens with them. When they parasitize migrating birds, these journeys can take them thousands of miles away from their usual geographic range. Historically, they haven’t been able to establish themselves, due to unsuitable climate conditions at the other end of their long journeys. But now, thanks to the climate crisis, it’s getting easier for ticks to survive and spread, potentially bringing novel tick-borne pathogens with them. “If conditions become more hospitable for tropical tick species to establish themselves in areas where they would previously have been unsuccessful, then there is a chance they could bring new diseases ...

Diabetes drug shows promise in protecting kidneys

2024-11-18

Type 2 diabetes can lead to diabetic kidney disease, but a class of drugs that cause the kidneys to remove glucose through urine has been gaining attention. An Osaka Metropolitan University-led research group has investigated how such drugs maintain kidney health. Known as SGLT2 (sodium-glucose cotransporter-2) inhibitors, the drugs are used to treat type 2 diabetes along with an exercise and diet regimen. The group led by Graduate School of Medicine Associate Professor Katsuhito Mori focused on the SGLT2 inhibitor canagliflozin and its effects on the kidney. Using BOLD ...

Updated model reduces liver transplant disparities for women

2024-11-18

SAN DIEGO, California (Nov. 18, 2024) — Since the adoption of a new model for assessing the severity of liver disease, women are more likely to be added to the waitlist for a liver transplant, more likely to receive a transplant, and less likely to drop off the waitlist — closing the gap between men and women candidates, according to a study scheduled for presentation today at The Liver Meeting held by the American Association for the Study of Liver Diseases. In July 2023, the federal Organ Procurement and Transplant Network (OPTN) updated its Model for End-Stage Liver Disease to a new version, known as MELD 3.0, to better account for differences between ...

Risk of internal bleeding doubles when people on anticoagulants take NSAID painkiller

2024-11-18

People who take an anticoagulant medicine double their risk of an internal bleed if they take a type of painkiller called a non-steroidal anti-inflammatory drug (NSAID) such as ibuprofen, diclofenac or naproxen, according to research published in the European Heart Journal [1] today (Monday). Anticoagulants are usually prescribed to people who develop a blood clot in the legs or lungs, known as a venous thromboembolism, which affects about one in 12 people. NSAIDs are a popular type of painkiller used to manage issues like headaches, period pain, back pain and arthritis. The new study is the largest of its kind and shows that ...

Study reveals significant global disparities in cancer care across different countries

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: